Sort
85,873 grants matching “alzheimers”
Targeting a Novel Regulator of Brain Aging and Alzheimer's Disease
$976,136Bruce A Yankner · Harvard Medical School · R01 · FY2016 · AG
Olera - Online Platform to Increase Access to Personalized Educational and Professional Assistance for AD/ADRD Caregivers
$975,931Tokunbo Falohun · Olera Inc. · R44 · FY2023 · AG
Study of cell-type specific Alzheimer's disease genetic variants using a novel bioengineered model of iPSC-derived neural tissue
$975,889Giuseppina Tesco · Tufts University Boston · R01 · FY2020 · AG
Study of cell-type specific Alzheimer's disease genetic variants using a novel bioengineered model of iPSC-derived neural tissue
$975,889Giuseppina Tesco · Tufts University Boston · R01 · FY2024 · AG
Study of cell-type specific Alzheimer's disease genetic variants using a novel bioengineered model of iPSC-derived neural tissue
$975,889Giuseppina Tesco · Tufts University Boston · R01 · FY2023 · AG
Study of cell-type specific Alzheimer's disease genetic variants using a novel bioengineered model of iPSC-derived neural tissue
$975,889Giuseppina Tesco · Tufts University Boston · R01 · FY2021 · AG
Study of cell-type specific Alzheimer's disease genetic variants using a novel bioengineered model of iPSC-derived neural tissue
$975,889Giuseppina Tesco · Tufts University Boston · R01 · FY2022 · AG
Longitudinal Molecular Imaging of Neuropathology and Serotonin in Mild Cognitive Impairment
$975,825Gwenn S Smith · Johns Hopkins University · R01 · FY2018 · AG
Circuitry underlying response summation in mouse and primate: Theory and experiment
$975,820John H Reynolds · Salk Institute For Biological Studies · U01 · FY2018 · NS
Discovering Centrally Linked Peripheral Molecular Signatures of Alzheimer's Disease
$975,754Nilufer Ertekin-Taner · Mayo Clinic Jacksonville · U19 · FY2023 · AG
Core B: University of Kentucky Alzheimer's Disease Core Center
$975,595Gregory A Jicha · University Of Kentucky · P30 · FY2022 · AG
Long-term toxicology studies for Posiphen; 6 month in rats and 9 months in dogs
$975,429Maria Maccecchini · Annovis Bio, Inc. · U01 · FY2020 · AG
The hCNS-HIV/ARV assay system, a platform utilizing human iPSC-neurons/-microglia/-astrocytes to test HIV/AIDS therapeutics for neurotoxicity related to HIV-associated cognitive disroder (HAND)
$975,197Patrick M McDonough · Vala Sciences, Inc. · R44 · FY2021 · MH
Regulation of Neuronal Excitability
$975,181Daniel Johnston · University Of Texas At Austin · P01 · FY2007 · NS
"A Novel Role for the UPR Component, ATF6 in AD-associated Neuroprotective Pathways"
$974,957Randal J. Kaufman · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2023 · AG
Mechanism and function of autosomal analog of X inactivation
$974,914Alexander Gimelbrant · Dana-Farber Cancer Inst · R01 · FY2017 · GM
Mechanism and function of autosomal analog of X inactivation
$974,914Alexander Gimelbrant · Dana-Farber Cancer Inst · R01 · FY2016 · GM
Mechanism and function of autosomal analog of X inactivation
$974,914Alexander Gimelbrant · Dana-Farber Cancer Inst · R01 · FY2018 · GM
Magnetic Resonance Spectroscopy Core Facility
$974,850Jun Shen · National Institute Of Mental Health · ZIC · FY2019 · MH
Aging in 1000 healthy midlife adults: Phase 52 of the Dunedin Study
$974,822Terrie Edith Moffitt · Duke University · R01 · FY2024 · AG
"A Novel Role for the UPR Component, ATF6 in AD-associated Neuroprotective Pathways"
$974,758Randal J. Kaufman · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2022 · AG
Development of a chemical reaction sensor array platform for label-free, real-time kinetic analysis of enzyme-substrate reactions to enable high-throughput drug discovery
$974,700Bharath Takulapalli · Spoc Proteomics Inc. · R44 · FY2022 · TR
Clinical Core
$974,596Douglas R Galasko · University Of California, San Diego · P50 · FY2017 · AG
HOME BASED ASSESSMENT OF ELDERLY AT RISK FOR COGNITIVE DECLINE, MCI AND AD
$974,570Mary Sano · University Of California, San Diego · U01 · FY2010 · AG
Metabolic Networks and Pathways in Alzheimer's Disease
$974,544Rima F Kaddurah-Daouk · Duke University · R01 · FY2014 · AG